Kazia Therapeutics (KZIA) Cash from Operations (2016 - 2022)
Kazia Therapeutics (KZIA) posted Cash from Operations of 11571662.48 for Q4 2022, up 239.44% on a QoQ basis from 8298650.54 in Q4 2021, and up 239.44% year-over-year from 3409042.11 in Q4 2021.
Kazia Therapeutics (KZIA) Cash from Operations (2016 - 2022) Analysis & Trends
Kazia Therapeutics' Cash from Operations history runs 5 years deep, the most recent figure standing at 11571662.48 for Q4 2022.
- Quarterly Cash from Operations rose 239.44% year-over-year to 11571662.48 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 7564394.61 (up 69.62% YoY) and the FY2025 annual result came in at 8503672.07, down 34.68% from the prior year.
- Cash from Operations was 11571662.48 for Q4 2022 at Kazia Therapeutics, up from 8298650.54 in the prior quarter.
- Across five years, Cash from Operations topped out at 11571662.48 in Q4 2022 and bottomed at 8968061.66 in Q4 2020.
- A 4-year average of 1891098.65 and a median of 5083997.71 in 2019 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2020 — Cash from Operations plunged 379.74% — and 2022, when it surged 239.44%.
- Kazia Therapeutics' Cash from Operations stood at 1869344.88 in 2019, then plunged by 379.74% to 8968061.66 in 2020, then increased by 7.46% to 8298650.54 in 2021, then jumped by 239.44% to 11571662.48 in 2022.
- Business Quant data shows KZIA's Cash from Operations at 11571662.48 in Q4 2022, 8298650.54 in Q4 2021, and 8968061.66 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.57 Mn |
| Dec 31, 2022 | 11.57 Mn |
| Dec 31, 2021 | -8.30 Mn |
| Dec 31, 2021 | -8.30 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Dec 31, 2019 | -1.87 Mn |
| Dec 31, 2019 | -1.87 Mn |
| Dec 31, 2016 | -5.77 Mn |
| Dec 31, 2016 | -5.77 Mn |